US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioCorRx Inc.

0.4000

0.0000

Volume:- -

Turnover:- -

Market Cap:10.56M

PE:-2.15

High:0.4000

Open:0.4000

Low:0.4000

Close:0.4000

52wk High:0.5000

52wk Low:0.1995

Shares:26.40M

Float Shares:8.60M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1861

EPS(LYR):-0.1861

ROE:145.76%

ROA:-238.42%

PB:-0.94

PE(LYR):-2.15

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BioCorRx issues 2.3 million unregistered shares in subsidiary stock exchange

BioCorRx FY25 net loss narrows to $3.5 million; revenue climbs to $797,244

Powell Max names Geordan Pursglove chairman and CEO

BioCorRx Inc. CEO to Present Live at Life Sciences Virtual Investor Forum

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BICX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BICX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BICX\",,,,,undefined,":{"symbol":"BICX","market":"US","secType":"STK","nameCN":"BioCorRx Inc.","latestPrice":0.4,"timestamp":1777566060000,"preClose":0.4,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":8599900,"shares":26402874,"eps":-0.186095,"marketStatus":"Trading","change":0,"latestTime":"04-30 12:21:00 EDT Delay","open":0.4,"high":0.4,"low":0.4,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.186095,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1777579200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.4,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BICX\",,,,,undefined,":{"symbol":"BICX","floatShares":8599900,"roa":"-238.42%","roe":"145.76%","lyrEps":-0.186095,"shares":26402874,"dividePrice":0,"high":0.4,"amplitude":0,"preClose":0.4,"low":0.4,"week52Low":0.1995,"pbRate":"-0.94","psRate":"13.25","week52High":0.5,"institutionHeld":0,"latestPrice":0.4,"eps":-0.186095,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.186095,"open":0.4,"prevYearClose":0.2911,"prevWeekClose":0.4066,"prevMonthClose":0.4,"prevQuarterClose":0.4,"fiveDayClose":0.4066,"twentyDayClose":0.4,"sixtyDayClose":0.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BICX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-14","symbol":"BICX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"BICX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-15","symbol":"BICX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-04-01","symbol":"BICX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1711944000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-14","symbol":"BICX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1691985600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BICX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BICX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BICX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624353684","title":"BioCorRx issues 2.3 million unregistered shares in subsidiary stock exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2624353684","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624353684?lang=en_us&edition=fundamental","pubTime":"2026-04-03 03:31","pubTimestamp":1775158306,"startTime":"0","endTime":"0","summary":"BioCorRx issued 2,263,371 unregistered common shares in a private transaction that closed March 27, 2026.Shares were exchanged for 1,215 BioCorRx Pharmaceuticals common shares, equal to about 12.15% of subsidiary outstanding stock.Transaction formed part of reorganization plan aimed at gaining tax-code control of subsidiary under Section 368.Issuance relied on Securities Act Section 4 exemption, with shares treated as restricted securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCorRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDLc5PyV3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BICX","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624559471","title":"BioCorRx FY25 net loss narrows to $3.5 million; revenue climbs to $797,244","url":"https://stock-news.laohu8.com/highlight/detail?id=2624559471","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624559471?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:44","pubTimestamp":1774997044,"startTime":"0","endTime":"0","summary":"BioCorRx posted a net loss of $3.51 million in fiscal 2025, narrowing from $5.21 million a year earlier.Revenue jumped to $797,244 in 2025, up 10,301.1% year over year.BioCorRx Pharmaceuticals bought Lucemyra assets from US WorldMeds, with supply and distribution net sales of $795,454.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCorRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL4vMDnm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","BICX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618626333","title":"Powell Max names Geordan Pursglove chairman and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2618626333","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618626333?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:30","pubTimestamp":1773059456,"startTime":"0","endTime":"0","summary":"Powell Max appointed Geordan Pursglove as chairman and CEO. Pursglove is chairman and CEO of Lixte Biotechnology and managing director of 2GP Group. The company also added Andrew Hancox, Phillip Balatsos, Caroline Castleforte, and Lourdes Felix to its board. Hancox is founder and managing member of Block 8 Ventures, while Felix is CEO and CFO of BioCorRx.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDLbpJfm8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014039.USD","SG9999014013.SGD","IE00BGHQF748.EUR","PMAX","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014021.USD","BK4585","LU2210149790.SGD","LU2095319765.USD","BICX","LIXT","SG9999014005.SGD","BK4112","LU2210150020.SGD","IE00BKPKM429.USD","BK4139","BK4185","IE00B3QW5Z07.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590580836","title":"BioCorRx Inc. CEO to Present Live at Life Sciences Virtual Investor Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2590580836","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590580836?lang=en_us&edition=fundamental","pubTime":"2025-12-10 21:35","pubTimestamp":1765373710,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCorRx Inc. published the original content used to generate this news brief via GlobeNewswire  on December 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL9Fr2Jw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2095319765.USD","LU2210150020.SGD","LU0314104364.USD","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","IE00B64PRP62.GBP","NDAQ","IE00B3QW5Z07.USD","BK4585","SG9999014013.SGD","BK4185","SG9999014005.SGD","BK4112","LU2210149790.SGD","BK4588","BICX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BICX\",params:#limit:6,delay:false,,,undefined,":[]}}